These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 3829343)

  • 1. Idiopathic ventricular fibrillation: inducibility and beneficial effects of class I antiarrhythmic agents.
    Belhassen B; Shapira I; Shoshani D; Paredes A; Miller H; Laniado S
    Circulation; 1987 Apr; 75(4):809-16. PubMed ID: 3829343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Idiopathic ventricular fibrillation: clinical, electrophysiologic characteristics and long-term outcomes.
    Tsai CF; Chen SA; Tai CT; Chiang CE; Ding YA; Chang MS
    Int J Cardiol; 1998 Mar; 64(1):47-55. PubMed ID: 9579816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 25-year control of idiopathic ventricular fibrillation with electrophysiologic-guided antiarrhythmic drug therapy.
    Belhassen B
    Heart Rhythm; 2004 Sep; 1(3):352-4. PubMed ID: 15851183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of Brugada Syndrome: Thirty-Three-Year Experience Using Electrophysiologically Guided Therapy With Class 1A Antiarrhythmic Drugs.
    Belhassen B; Rahkovich M; Michowitz Y; Glick A; Viskin S
    Circ Arrhythm Electrophysiol; 2015 Dec; 8(6):1393-402. PubMed ID: 26354972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrophysiologic assessment of antiarrhythmic drug efficacy for ventricular tachyarrhythmias associated with dilated cardiomyopathy.
    Rae AP; Spielman SR; Kutalek SP; Kay HR; Horowitz LN
    Am J Cardiol; 1987 Feb; 59(4):291-5. PubMed ID: 3544793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of electrophysiologic-guided therapy with Class IA antiarrhythmic drugs on the long-term outcome of patients with idiopathic ventricular fibrillation with or without the Brugada syndrome.
    Belhassen B; Viskin S; Fish R; Glick A; Setbon I; Eldar M
    J Cardiovasc Electrophysiol; 1999 Oct; 10(10):1301-12. PubMed ID: 10515552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unfavorable outcome in patients with primary electrical disease who survived an episode of ventricular fibrillation.
    Wever EF; Hauer RN; Oomen A; Peters RH; Bakker PF; Robles de Medina EO
    Circulation; 1993 Sep; 88(3):1021-9. PubMed ID: 8353864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent sustained ventricular tachycardia 3. Role of the electrophysiologic study in selection of antiarrhythmic regimens.
    Horowitz LN; Josephson ME; Farshidi A; Spielman SR; Michelson EL; Greenspan AM
    Circulation; 1978 Dec; 58(6):986-97. PubMed ID: 709782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Programmed ventricular stimulation in predicting vulnerability to ventricular arrhythmias and their response to antiarrhythmic therapy.
    Mason JW; Swerdlow CD; Winkle RA; Griffin JC; Ross DL; Keefe DL; Clusin WT
    Am Heart J; 1982 Apr; 103(4 Pt 2):633-9. PubMed ID: 7064805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of the signal-averaged electrocardiogram in patients presenting with sustained ventricular tachycardia or fibrillation while on an antiarrhythmic drug.
    Nalos PC; Gang ES; Mandel WJ; Myers MR; Oseran DS; Lass Y; Peter T
    Am Heart J; 1988 Jan; 115(1 Pt 1):108-14. PubMed ID: 3336965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiarrhythmic effects of selective prolongation of refractoriness. Electrophysiologic actions of sematilide HCl in humans.
    Sager PT; Nademanee K; Antimisiaris M; Pacifico A; Pruitt C; Godfrey R; Singh BN
    Circulation; 1993 Sep; 88(3):1072-82. PubMed ID: 8353869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrode-catheter arrhythmia induction in the selection and assessment of antiarrhythmic drug therapy for recurrent ventricular tachycardia.
    Mason JW; Winkle RA
    Circulation; 1978 Dec; 58(6):971-85. PubMed ID: 709781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Excellent long-term reproducibility of the electrophysiologic efficacy of quinidine in patients with idiopathic ventricular fibrillation and Brugada syndrome.
    Belhassen B; Glick A; Viskin S
    Pacing Clin Electrophysiol; 2009 Mar; 32(3):294-301. PubMed ID: 19272057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discrepant drug action of disopyramide on ECG abnormalities and induction of ventricular arrhythmias in a patient with Brugada syndrome.
    Chinushi M; Aizawa Y; Ogawa Y; Shiba M; Takahashi K
    J Electrocardiol; 1997 Apr; 30(2):133-6. PubMed ID: 9141608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of serial electropharmacological testing in managing patients resuscitated from cardiac arrest.
    Raviele A; Di Pede F; Delise P; Piccolo E
    Pacing Clin Electrophysiol; 1984 Sep; 7(5):850-60. PubMed ID: 6207498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Torsades de pointes: electrophysiologic studies in patients without transient pharmacologic or metabolic abnormalities.
    Horowitz LN; Greenspan AM; Spielman SR; Josephson ME
    Circulation; 1981 May; 63(5):1120-8. PubMed ID: 7471373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics of patients with ventricular fibrillation during antiarrhythmic drug therapy.
    Minardo JD; Heger JJ; Miles WM; Zipes DP; Prystowsky EN
    N Engl J Med; 1988 Aug; 319(5):257-62. PubMed ID: 3393179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proarrhythmic effects of antiarrhythmic drugs in patients with malignant ventricular arrhythmias evaluated by electrophysiologic testing.
    Rae AP; Kay HR; Horowitz LN; Spielman SR; Greenspan AM
    J Am Coll Cardiol; 1988 Jul; 12(1):131-9. PubMed ID: 3379198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrophysiological findings in idiopathic recurrent ventricular fibrillation: special reference to mode of induction, drug testing, and long-term outcomes.
    Aizawa Y; Naitoh N; Washizuka T; Takahashi K; Uchiyama H; Shiba M; Shibata A
    Pacing Clin Electrophysiol; 1996 Jun; 19(6):929-39. PubMed ID: 8774823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of nonsustained ventricular tachycardia as a guide to antiarrhythmic drug therapy in patients with malignant ventricular arrhythmia.
    Podrid PJ; Schoeneberger A; Lown B; Lampert S; Matos J; Porterfield J; Raeder E; Corrigan E
    Am Heart J; 1983 Feb; 105(2):181-8. PubMed ID: 6823797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.